Article

New lab sparks sales of Teflon lens coating

Atlanta?Robertson Optical Laboratories Inc. has clocked major growth in Teflon Clear Coat Lens sales since the firm opened its new anti-reflective (AR) coating laboratory in September 2005, according to Mike Fussell, Robertson's sales and customer service manager.

Atlanta-Robertson Optical Laboratories Inc. has clocked major growth in Teflon Clear Coat Lens sales since the firm opened its new anti-reflective (AR) coating laboratory in September 2005, according to Mike Fussell, Robertson's sales and customer service manager.

Robertson is the only independently owned lab in the southeast that is approved to produce Teflon Clear Coat Lenses in-house.

"While Robertson is enjoying the growth in Teflon Clear Coat Lens sales, the real winners are area eye-care professionals and their patients," said Christie Cornetta, regional marketing manager–east, Carl Zeiss Vision. "AR is the biggest segment of the optical industry that will fuel growth for eye-care professionals now and in the future."

"We are now able to offer premium AR coatings with the quality and service that our customers expect from us," added Fussell. "Our customers see that the combination of great AR performance through our new lab and the powerful Teflon brand can help their AR businesses grow significantly.

"We are succeeding because they are succeeding."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.